Premil 1 mg (Tablet)
Unit Price: ৳ 3.00 (3 x 10: ৳ 90.00)
Strip Price: ৳ 30.00
Medicine Details
Category | Details |
---|---|
Generic | Repaglinide |
Company | Beximco pharmaceuticals ltd |
Also available as |
Indications
- Adjunct to diet and exercise for lowering blood glucose in patients with type 2 diabetes mellitus
- Use in combination with Metformin for lowering blood glucose
Description
Oral blood-glucose-lowering drug of the meglitinide class used in the management of Type 2 diabetes mellitus
Pharmacology
- Binds to specific receptors in the cell membrane
- Leads to closure of ATP dependent K+ channels and depolarization of cell membrane
- Leads to increased intracellular Ca++ and stimulation of insulin secretion
Dosage & Administration
- Starting dose of 0.5 mg for patients not previously treated or with HbA1c <8%
- Initial dose of 1 or 2 mg for patients previously treated with blood glucose-lowering drugs and HbA1c >8%
- Taken immediately or up to 30 minutes before each meal
- Dosage adjusted according to response at intervals of 1-2 weeks
Interaction
- Inhibitors of cytochrome P450 enzyme system may lead to lower clearance and longer half-life
- Inducers of cytochrome P450 enzyme system may accelerate metabolism
- Cimetidine has no significant effect on absorption or clearance
- No significant effect on certain drugs like Digoxin, Theophyllin, or Warfarin
- Increased risk of hypoglycemia when co-administered with certain drugs such as salicylates, sulphonamides, Chloramphenicol, coumarins, Probenecid, monoamine oxidase (MAO) inhibitors, and adrenergic blockers
Contraindications
- Diabetic ketoacidosis
- Type 1 diabetes mellitus
- Known hypersensitivity to the drug or its inactive ingredients
Side Effects
- Hypoglycemia and related symptoms
- Upper respiratory tract infections
- Diarrhea
- Constipation
- Nausea and vomiting
- Hypersensitivity reactions like rashes and urticaria
Pregnancy & Lactation
- Safety during pregnancy not established
- Should be used during pregnancy only if clearly needed
- Not known whether excreted in human milk
- Decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother
Precautions & Warnings
- Insulin should be substituted during concurrent illness and surgery
- All oral blood glucose-lowering drugs are capable of producing hypoglycemia
- Should be administered with meals to lessen the risk of hypoglycemia
Overdose Effects
- Patients receiving up to 80 mg developed few adverse effects other than lowering of blood glucose
- Severe hypoglycemic reactions occur infrequently
Therapeutic Class
Meglitinide Analogues
Storage Conditions
Do not store above 30°C. Keep away from light and out of the reach of children.